To further address this issue, we performed additional experiments to examine the expression of NPM1, ribosomal protein L5 (RPL5), and Puf-A in clinical NSCLC specimens with high and low expression of Puf-A, using Opal multiplex immunofluorescence assay. The gene discussed is PUM3; the disease is non-small cell lung carcinoma.